コントロールされた臨床試験と医療倫理

R Burkhardt, G Kienle

Lancet (London, England)

|December 23, 1978

まとめ

ドイツにおける臨床試験をめぐる法的,倫理的な問題は,懸念が高まっています. 実験のための契約を導入することで,個々の患者の利益と試験の要件との間の衝突を解決することができます.

科学分野:

医療法医療法医療法について
バイオエシックバイオエシック

背景:

ドイツの世論は,過去5年間にわたり,臨床試験の法的および倫理的側面に焦点を当てている.
治療契約に基づく医師の義務は,治験の倫理的要件と矛盾し,治験の実施を阻害する可能性がある.

研究の目的:

ドイツ連邦共和国における臨床試験による法的・倫理的課題を検証する.
臨床試験の実施における倫理的および法的障壁を克服するための潜在的な解決策を探求すること.

主な方法:

臨床試験に関する法的および倫理的枠組みの分析.
既存の医師と患者の治療契約の検討と,その研究への影響.

主要な成果:

標準治療契約は,臨床試験における医師にとって倫理的なジレンマを生む可能性があります.
治療契約における個人利益の原則は,臨床試験における比較データの必要性と矛盾することがあります.

結論:

コントロールされた臨床試験の法的および倫理的な複雑さをナビゲートするために,別々の"実験契約"が必要になる可能性があります.
専門的な契約の実施は,臨床試験のプロトコルと医師の義務を調和させ,倫理的行動と法的遵守を確保するのに役立ちます.

さらに関連する動画

04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

04:11

A Video Protocol of a Randomized Controlled Clinical Trial - Electrochemotherapy of Cutaneous Metastases with Reduced Dose Bleomycin (BLESS Trial)

Published on: June 9, 2026

関連する概念動画

01:56

Ethics in Research

Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.

01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...

01:11

Blinding

Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.

01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...

01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...

01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...

関連する実験動画